Chris has dedicated his 16-year career to the services side of the Phase 1 clinical drug development industry, including both operational and business development roles. Starting as a Clinical Research Coordinator and Project Manager at Charles River Clinical Services (formerly Northwest Kinetics) where he was directly responsible for the delivery of many Phase 1 clinical studies, was instrumental in his future success in a business development role.
After joining SNBL CPC in 2010, Chris had an active field-based BD role in the US and was responsible for delivering a large majority of the business into the Phase 1 unit during his tenure. Assuming responsibility for the management of the BD function as Vice President in 2015, he was a key member of the team that delivered on corporate growth objectives by building, training and managing a high performing field-based sales team.
This effort helped lead to the acquisition of SNBL CPC by Pharmaron Inc. in 2017. After the acquisition he remained a key resource for the Pharmaron executive management team during the transition period, assisting in the integration of the US Clinical Development team within the global Pharmaron organization. He continued to lead the global business development effort for the US based Phase 1 unit for four years.
Chris’ deep knowledge of the global early phase drug development industry will strengthen the tradition of success for our company, customers and partners.